Are single-dose toxicology studies in animals adequate to support single doses of a new drug in humans?
Authors:
- 5 March 1996
- journal article
- Published by Springer Nature in Clinical Pharmacology & Therapeutics
- Vol. 59 (3) , 258-264
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Predictability of clinical adverse reactions of drugs by general pharmacology studies.The Journal of Toxicological Sciences, 1995
- History of drugs for thrombotic disease. Discovery, development, and directions for the future.Circulation, 1994
- Idiosyncratic drug reactions: a mechanistic evaluation of risk factors.British Journal of Clinical Pharmacology, 1992
- Incorporation of Clinical Pharmacology Into the Fourth Year of the Medical Curriculum: Teaching Clinical Pharmacology Without a Clinical PharmacologistThe Journal of Clinical Pharmacology, 1990
- New Drugs: First Time in ManThe Journal of Clinical Pharmacology, 1989
- Pharmaceutical innovation by the seven UK‐owned pharmaceutical companies (1964‐1985).British Journal of Clinical Pharmacology, 1988
- Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.Circulation, 1986
- Medical research on normal volunteers [letter]British Journal of Clinical Pharmacology, 1986
- Clinically significant adverse effects in a Phase 1 testing programClinical Pharmacology & Therapeutics, 1978
- The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in manClinical Pharmacology & Therapeutics, 1970